Moreno Jiménez, María José
(Date of defense: 10-06-2014)
Diffuse large B-cell lymphoma (DLBCL) is a clinically and genetically heterogeneous disease, accounting for 30% of all non-Hodgkin lymphoma cases. Although the addition of rituximab to standard treatment (CHOP: cyclophosphamide, ...